Norimitsu Kadowaki

11.5k total citations · 4 hit papers
170 papers, 9.0k citations indexed

About

Norimitsu Kadowaki is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Norimitsu Kadowaki has authored 170 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Immunology, 45 papers in Oncology and 31 papers in Hematology. Recurrent topics in Norimitsu Kadowaki's work include Immunotherapy and Immune Responses (37 papers), Immune Cell Function and Interaction (30 papers) and T-cell and B-cell Immunology (21 papers). Norimitsu Kadowaki is often cited by papers focused on Immunotherapy and Immune Responses (37 papers), Immune Cell Function and Interaction (30 papers) and T-cell and B-cell Immunology (21 papers). Norimitsu Kadowaki collaborates with scholars based in Japan, United States and France. Norimitsu Kadowaki's co-authors include S. V. Antonenko, Yong-Jun Liu, Stephen Ho, René de Waal Malefyt, Vassili Soumelis, Marie‐Clotilde Rissoan, Robert A. Kastelein, Fernando Bazán, Michael Shodell and Yongjun Liu and has published in prestigious journals such as Science, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Norimitsu Kadowaki

154 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood

1999 1.8k citations Norimitsu Kadowaki et al. profile →
Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens

2001 1.6k citations Norimitsu Kadowaki et al. profile →
Reciprocal Control of T Helper Cell and Dendritic Cell Differentiation

1999 1.5k citations Norimitsu Kadowaki et al. profile →
Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity

2000 691 citations Norimitsu Kadowaki et al. profile →

Peers

Countries citing papers authored by Norimitsu Kadowaki

Since Specialization

Citations

This map shows the geographic impact of Norimitsu Kadowaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norimitsu Kadowaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norimitsu Kadowaki more than expected).

Fields of papers citing papers by Norimitsu Kadowaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norimitsu Kadowaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norimitsu Kadowaki. The network helps show where Norimitsu Kadowaki may publish in the future.

Co-authorship network of co-authors of Norimitsu Kadowaki

This figure shows the co-authorship network connecting the top 25 collaborators of Norimitsu Kadowaki. A scholar is included among the top collaborators of Norimitsu Kadowaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norimitsu Kadowaki. Norimitsu Kadowaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antitumor Effects of Combination Therapy with Oncolytic Vaccinia Virus and Tepotinib on Lung Cancer Cells 2025 ·Cancers ·Takuya Inoue, Nobuhiro Kanaji, Takafumi Nakamura, Masanao Yokohira, Y. Komori, (unknown), (unknown), Naoki Watanabe, Norimitsu Kadowaki	0
2	Immune Checkpoint Inhibitor-Induced Insidiously Progressive, Fatal Interstitial Lung Disease 2025 ·Journal of Personalized Medicine ·Nobuhiro Kanaji, Naoki Watanabe, Takuya Inoue, (unknown), (unknown), (unknown), Norimitsu Kadowaki	1
3	Efficacy of favipiravir treatment for patients with severe fever with thrombocytopenia syndrome assessed with a historical control 2025 ·Antimicrobial Agents and Chemotherapy ·Masayuki Saijo, Koichi Izumikawa, Koichiro Suemori, Toru Takahashi, Kunihiko Umekita, Hiroki Ohge, (unknown), (unknown), Daisuke Himeji, Atsushi Yamanaka, Norimitsu Kadowaki, Masafumi Kawamura, Yasuyuki Kakihana, Takuo Ito, Kisato Nosaka, Tsutomu Sakurai, Tomoki Yoshikawa, Takeshi Kurosu, Masayuki Shimojima, (unknown)	0
4	Efficacy and Safety of Re-administration of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) After EGFR-TKI-Induced Interstitial Lung Disease (CS-Lung-005) 2024 ·Lung ·Nobuhiro Kanaji, Eiki Ichihara, Takaaki Tanaka, Takashi Ninomiya, Toshiyuki Kozuki, Nobuhisa Ishikawa, Kazuya Nishii, (unknown), Kakuhiro Yamaguchi, (unknown), Yuko Toyoda, Masaaki Inoue, Nobuyuki Miyatake, Naoki Watanabe, Takuya Inoue, (unknown), (unknown), (unknown), Norimitsu Kadowaki	5
5	Immunological disease activity parameters at conception are risk factors for preterm birth and low birth weight in patients with systemic lupus erythematosus 2023 ·Lupus ·Hiromi Shimada, (unknown), Tomohiro Kameda, S. Nakashima, (unknown), (unknown), Yusuke Ushio, (unknown), (unknown), (unknown), Kenji Kanenishi, Norimitsu Kadowaki, Hiroaki Dobashi	1
6	Humoral immune response against BNT162b2 mRNA COVID-19 vaccine in patients with rheumatic disease undergoing immunosuppressive therapy: A Japanese monocentric study 2022 ·Medicine ·(unknown), (unknown), Tomohiro Kameda, Hiromi Shimada, S. Nakashima, (unknown), (unknown), Yusuke Ushio, (unknown), (unknown), (unknown), (unknown), (unknown), Norimitsu Kadowaki, Hiroaki Dobashi	3
7	Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease 2022 ·Clinical Rheumatology ·(unknown), (unknown), Hiromi Shimada, S. Nakashima, Tomohiro Kameda, Nobuyuki Miyatake, (unknown), (unknown), (unknown), (unknown), (unknown), Norimitsu Kadowaki, Hiroaki Dobashi	3
8	Efficacy and safety of apremilast and its impact on serum cytokine levels in patients with Behçet's disease 2022 ·Dermatologic Therapy ·(unknown), Yusuke Ushio, (unknown), Tomohiro Kameda, Hiromi Shimada, S. Nakashima, (unknown), (unknown), (unknown), (unknown), (unknown), Norimitsu Kadowaki, Hiroaki Dobashi	4
9	Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case report 2021 ·Allergy Asthma and Clinical Immunology ·(unknown), (unknown), Hiromi Shimada, (unknown), Tomohiro Kameda, S. Nakashima, (unknown), Yusuke Ushio, Norimitsu Kadowaki, Hiroaki Dobashi	4
10	NK and NKT Cell-Mediated Immune Surveillance against Hematological Malignancies 2020 ·Cancers ·Kanako Shimizu, Tomonori Iyoda, Satoru Yamasaki, Norimitsu Kadowaki, Arinobu Tojo, Shin‐ichiro Fujii	22
11	Oncolytic herpes simplex virus type 1 (HSV‐1) in combination with lenalidomide for plasma cell neoplasms 2020 ·British Journal of Haematology ·(unknown), (unknown), (unknown), Osamu Imataki, Naoshi Sugimoto, Tomoki Todo, Norimitsu Kadowaki	17
12	Sequential change in serum VEGF levels in a case of tocilizumab-resistant TAFRO syndrome treated effectively with rituximab 2020 ·Modern Rheumatology Case Reports ·(unknown), Tomohiro Kameda, (unknown), Hiroki Ozaki, S. Nakashima, Hiromi Shimada, Norimitsu Kadowaki, Hiroaki Dobashi	8
13	Oncolytic Virus Therapy with HSV-1 for Hematological Malignancies 2020 ·Molecular Therapy ·(unknown), (unknown), Toshio Heike, Naoshi Sugimoto, (unknown), (unknown), Osamu Imataki, (unknown), Teruhisa Taoka, (unknown), Toin H. Van Kuppevelt, Tomoki Todo, Akifumi Takaori‐Kondo, Norimitsu Kadowaki	26
14	Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus 2019 ·Lupus ·(unknown), Tomohiro Kameda, (unknown), S. Nakashima, Hiromi Shimada, (unknown), (unknown), (unknown), Nobuyuki Miyatake, Norimitsu Kadowaki, Hiroaki Dobashi	13
15	Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation 2018 ·Therapeutics and Clinical Risk Management ·Nobuhiro Kanaji, (unknown), Takuya Inoue, (unknown), Naoki Watanabe, Tomoya Ishii, Yasunori Tojo, Masahiro Yamaguchi, Norimitsu Kadowaki	13
16	The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions 2018 ·BMC Pulmonary Medicine ·Naoki Watanabe, Tomoya Ishii, Nobuyuki Kita, Nobuhiro Kanaji, Hiroyuki Nakamura, (unknown), Yutaka Ueda, Yasunori Tojo, Norimitsu Kadowaki, Shuji Bandoh	15
17	Infective endocarditis and infected aneurysm caused by Streptococcus dysgalactiae subsp. equisimilis : a case report 2017 ·Clinical Case Reports ·Naoki Watanabe, Shuji Bandoh, Tomoya Ishii, Kiyoshi Negayama, Norimitsu Kadowaki, Kyoko Yokota	8
18	Phanerochaete sordida as a cause of pulmonary nodule in an immunocompromised patient: a case report 2017 ·BMC Infectious Diseases ·Naoki Watanabe, Kiyofumi Ohkusu, (unknown), Osamu Imataki, Tomoya Ishii, Kiyoshi Negayama, (unknown), Nobuyuki Kita, Takehiro Takagi, Nobuhiro Kanaji, Norimitsu Kadowaki, Shuji Bandoh	6
19	Regeneration of CD8αβ T Cells from T-cell–Derived iPSC Imparts Potent Tumor Antigen-Specific Cytotoxicity 2016 ·Cancer Research ·Takuya Maeda, Seiji Nagano, Hiroshi Ichise, Keisuke Kataoka, Daisuke Yamada, Seishi Ogawa, Haruhiko Koseki, Toshio Heike, Norimitsu Kadowaki, Akifumi Takaori‐Kondo, Kyoko Masuda, Hiroshi Kawamoto	90
20	Hypomethylation of the Treg-Specific Demethylated Region in FOXP3 Is a Hallmark of the Regulatory T-cell Subtype in Adult T-cell Leukemia 2016 ·Cancer Immunology Research ·(unknown), Yutaka Shimazu, Masakatsu Hishizawa, Masahide Hamaguchi, Yuya Nagai, (unknown), Sumie Fujii, Masahiro Kawahara, Norimitsu Kadowaki, Hiroyoshi Nishikawa, Shimon Sakaguchi, Akifumi Takaori‐Kondo	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact